Midland Wealth Advisors LLC Sells 127 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Midland Wealth Advisors LLC reduced its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 5.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,400 shares of the company’s stock after selling 127 shares during the period. Midland Wealth Advisors LLC’s holdings in HCA Healthcare were worth $720,000 at the end of the most recent reporting period.

Other large investors have also recently modified their holdings of the company. Van ECK Associates Corp acquired a new position in HCA Healthcare during the third quarter worth about $752,000. Capital Performance Advisors LLP bought a new position in HCA Healthcare in the 3rd quarter valued at approximately $41,000. CWA Asset Management Group LLC bought a new position in shares of HCA Healthcare in the 3rd quarter valued at $2,874,000. Assetmark Inc. grew its position in HCA Healthcare by 5.5% during the 3rd quarter. Assetmark Inc. now owns 1,834 shares of the company’s stock worth $746,000 after acquiring an additional 96 shares during the last quarter. Finally, Atria Investments Inc raised its position in HCA Healthcare by 14.8% in the third quarter. Atria Investments Inc now owns 5,724 shares of the company’s stock valued at $2,326,000 after purchasing an additional 736 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Price Performance

Shares of HCA opened at $330.11 on Monday. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14. The stock has a market cap of $81.27 billion, a P/E ratio of 15.03, a P/E/G ratio of 1.10 and a beta of 1.68. The business’s fifty day moving average is $316.70 and its 200 day moving average is $347.29. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period in the previous year, the business posted $5.90 EPS. Sell-side analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Investors of record on Monday, March 17th will be given a dividend of $0.72 per share. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.87%. The ex-dividend date is Monday, March 17th. HCA Healthcare’s dividend payout ratio (DPR) is presently 13.11%.

Insiders Place Their Bets

In other news, SVP Jennifer Berres sold 9,533 shares of HCA Healthcare stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the sale, the senior vice president now directly owns 15,412 shares in the company, valued at $4,971,757.08. The trade was a 38.22 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 1.60% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on the company. Bank of America lowered their price objective on HCA Healthcare from $380.00 to $370.00 and set a “buy” rating for the company in a research note on Monday, January 27th. Wells Fargo & Company cut shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and reduced their price objective for the stock from $400.00 to $320.00 in a research note on Monday, November 25th. KeyCorp reduced their price target on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 7th. Barclays cut their price objective on HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a research note on Monday, January 27th. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $405.00 price target on shares of HCA Healthcare in a research report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $385.67.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.